Abstract:Background: Glycated albumin (GA) reflects serum glucose of the preceding 2 - 3 weeks and plays an important role in diabetes mellitus (DM). This study aimed at investigating whether GA can assess renal dysfunction in population.Methods: 3818 individuals attending physical examination were enrolled in this cross-sectional study and divided into five groups: healthy controls, impaired fasting glucose, DM without renal complications, DM with albuminuria, and nondiabetic chronic kidney disease patients. All analyses were conducted using the subjects with both fasting venous blood and morning urine samples.Results: Among all groups, mean GA, hemoglobin Alc, fasting plasma glucose, and serum creatinine were the highest and estimated glomerular filtration rate (eGFR) was the lowest in DM with albuminuria group. When eGFR was 90 - 105 mL/minute/1.73 m(2) or mildly decreased to 60 - 90 mL/minute/1.73 m(2), GA increased significantly with elevating albumin-to-creatinine ratio (ACR) from 0 - 10 mg/g to 10 - 30 mg/g to > 30 mg/g (p < 0.001 and p < 0.001). GA increased further when eGFR decreased moderately to severely as a result of renal function continuing to deteriorate (eGFR <= 60 mL/minute/1.73 m(2)).When ACR <= 30 mg/g and eGFR <= 60 mL/minute/1.73 m(2), more than 50% subjects were DM patients and had significantly higher GA levels than other subjects with eGFR > 105 mL/minute/1.73 m(2). After adjusting demographics, every 5% rise of GA levels showed a 1.778-fold increased risk in all subjects (adjusted odds ratio [OR], 1.778; 95% confidence interval [CI], 1.373 - 2.302; p < 0.001) and 1.737-fold risk in DM subjects (adjusted OR, 1.737; 95% CI, 1.221 - 2.471; p = 0.002) for occurrence of ACR > 30mg/g in contrast to ACR <= 30 mg/g. Compared to eGFR > 90 mL/minute/1.73 m(2), 5% rise of GA levels showed a 1.482-fold risk for eGFR 60 - 90 mL/minute/1.73 m(2) (adjusted OR, 1.482; 95% CI, 1.112 - 1.975; p = 0.007) and a 1.996-fold risk for eGFR <= 60 mL/minute/1.73 m(2) (adjusted OR, 1.996; 95% CI, 1.366 - 2.916; p < 0.001).Conclusions: Increased GA serves as a risk marker for renal dysfunction. GA combined with eGFR and ACR can reflect renal function changes in population.

Glycated albumin may have a complementary role to glycated hemoglobin in glucose monitoring in childhood acute leukemia

Association Between Glycated Albumin and Adverse Outcomes in Patients with Heart Failure.

Baseline glycated albumin level and risk of type 2 diabetes mellitus in Healthy individuals: a retrospective longitudinal observation in Korea

Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: A multicenter, prospective study

Elevated Serum HbA1c Level, Rather Than Previous History of Diabetes, Predicts the Disease Severity and Clinical Outcomes of Acute Pancreatitis

Glycated albumin:an effective marker for assessing glycemic control in diabetic inpatients

Primary Assessment of Enzymatic Measurement of Glycated Albumin

Relationship between glycated albumin and glycated hemoglobin according to glucose tolerance status: A multicenter study

Clinical Utility of Glycated Albumin in Type 2 Diabetic Patients

The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges

[A Multi-Center Clinical Study of the Reference Value of Serum Glycated Albumin].

Clinical significance of measurement of glycated albumin in impaired glucose regulation and newly diagnosed diabetes

Defining the Relationship Between Glycated Albumin and HBA1c in Individuals with a Diverse Spectrum of Glucose Metabolism

Assessment of Glycated Albumin As a Useful Indicator for Renal Dysfunction in Diabetic and Nondiabetic Population.

Glycated Albumin Level and Its Influential Factors in Type 2 Diabetes Mellitus

Glycated Albumin May Be A Choice, but Not an Alternative Marker of Glycated Hemoglobin for Glycemic Control Assessment in Diabetic Patients Undergoing Maintenance Hemodialysis

[The Clinical Application of Glycosylated Hemoglobin A1c and Glycated Albumin Values in Cirrhosis Patients with Hyperglycemia].

Glycated Albumin Versus HbA1c in the Evaluation of Glycemic Control in Patients with Diabetes and CKD

[Combined utility of hemoglobin A1c and glycated albumin in diabetic screening].

The Use of Glycemic Control of Glycated Albumin in CKD 3~5 Non-dialysis and Hemodialysis Patients with Diatebes

Glycated Albumin is Superior to Hemoglobin A1c for Evaluating the Presence and Severity of Coronary Artery Disease in Type 2 Diabetic Patients.